NANOBIOTIX (EPA:NANO) NANOBIOTIX Announces Oral Presentation of Final Results From a Phase 1 Dose Expansion Study Evaluating NBTXR3 in Head and Neck Cancer at the 65th Annual Meeting of the American Society for Radiation Oncology
Transparency directive : regulatory news
29/09/2023 22:15